CXCL12 and B-cell chronic lymphocytic leukemia: Interfering with the cross-talk between CLL and stromal cells in order to eliminate CLL cells from the protective microenvironment and sensitize CLL cells to conventional therapy can be done by targeting CXCL12/CXCR4 signaling (228, 229).